« Back to Record
Citation APA

Praga, C., Bergh, J., Bliss, J. M., Bonneterre, J., Cesana, B., Coombes, R. C., Fargeot, P., Folin, A., Fumoleau, P., Giuliani, R., Kerbrat, P., Hery, M., Nilsson, J., Onida, F., Piccart-Gebhart, M., Shepherd, L., Therasse, P., Wils, J., & Rogers, D. (2005). Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide. Journal of clinical oncology, 23(18), 4179-4191. doi:10.1200/JCO.2005.05.029


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/55389

Praga, C., Bergh, J., Bliss, J. M., Bonneterre, J., Cesana, B., Coombes, R. C., Fargeot, P., Folin, A., Fumoleau, P., Giuliani, R., Kerbrat, P., Hery, M., Nilsson, J., Onida, F., Piccart-Gebhart, M., Shepherd, L., Therasse, P., Wils, J., & Rogers, D. (2005). Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide. Journal of clinical oncology, 23(18), 4179-4191. doi:10.1200/JCO.2005.05.029